[1]
Leboyer M., Philippe A., Bouvard M. et al.: Whole blood serotonin
and plasma beta endorphin in autistic probands and their first degree
relatives. Biol Psychiatry 1999; 45: 158 – 163.
[2]
Williams J.G., Higgins J.P.T., Brayane C.E.G.: Systematic review of
prevalence studies of Autism Spectrum Disorders. Arch Dis Child 2006;
91: 8 – 15.
[3]
A Report from the Autism and Developmental Disabilities Monitoring
(ADDM) Network. ‘Prevalence of the Autism Spectrum Disorders in
Multiple Areas of the United States, Surveillance Years 2000 and 2002’.
on-line 2007, http://www.cdc.gov/mmwr/mmwr-ss.html.
[4]
Horvath K., Papadimitriou J.C., Rabsztyn A. et al.: Gastrointestinal
abnormalities in children with an autistic disorder. J Paediatr 1999; 135:
559 – 563.
[5]
Torrente F., Anthony A., Path M.R.C.: Focal enhanced gastritis in
regressive autism with features distinct from Crohns and Helicobacter
Pylori gastritis. Am J Gastroenterol 2004; 99: 598 – 605.
[6]
Torrente F., Ashwood P., Day R. et al.: Small intestinal enteropathy with
epithelial IgG and complement deposition in children with regressive
autism. Mol Psych 2002; 7: 375 – 382.
[7]
Van Heest R., Jones S., Giacomantonio M. et al.: Rectal prolapse in
autistic children. J Paediatr Surg 2004; 39: 643 – 644.
[8]
Afzal N., Murch S., Thirrupathy K. et al.: Constipation with acquired
mega-rectum in children with autism. Pediatrics 2003; 112: 939 – 942.
[9]
Valicenti-McDermott M., McVicar K., Rapin I. et al.: Frequency of
gastrointestinal symptoms in children with Autistic Spectrum Disorders
and association with a family history of autoimmune disease. J Dev
Behav Pediatr 2006; 27: 128-136.
[10]
Huang R.C., Palmer L.J., Forbes D.A.: Prevalence and pattern of childhood
abdominal pain in an Australian general practice. J Paed Child Health
2000; 36: 349 – 353.
[11]
Campo J.V., Bridge J., Ehman M. et al.: Recurrent abdominal pain, anxiety
and depression in primary care. Pediatrics 2004; 113: 817 – 824.
[12]
Cornish E.: Gluten and casein free diets in autism: a study of the effects
on food choice and nutrition. J Hum Nutr Dietet 2002; 15: 261 – 269.
[13]
Ledford J.R., Gast D.L.: Feeding problems in children with Autism
Spectrum Disorders. Focus Autism Other Dev Disabl 2006; 21: 154
– 166.
[14]
Trajkovski V., Petelichkowski A., Efinska Mladenovska O. et al.: Higher
plasma concentration of food specific antibodies in persons with an
autistic disorder in comparison to their siblings. Focus Autism Other Dev
Disabl 2008; 23(3): 176 – 185.
[15]
White JF.: Intestinal patho-physiology in autism. Exp Biol Med 2003;
228: 693 – 649.
[16]
Ming X., Brimacombe M., Chaaban J. et al.: Autism Spectrum Disorders:
Concurrent Clinical Disorders. J Child Neurology 2008; 23 (1): 6-13.
[17]
Anthony A., Bjnarson I., Sigthorrson G.: Fecal calprotectin levels
correlate with acute inflammation in autistic entero-colitis. Gut 2000; 46
(Suppl 2):A3.
[18]
Fernell E., Fagerbelk UE., Hellstrom PM.: No evidence for a clear link
between active intestinal inflammation and autism based on analyses
of fecal calprotectin and rectal nitric oxide. Acta Paediatrica 2007; 96:
1076 –1079.
[19]
Wakefield A.J., Puleston J.M., Montgomery S.M. et al.: Review article:
The concept of entero-colonic encephalopathy, autism and opioid
receptor ligands. Aliment Pharmacol Ther 2002; 16: 663 – 674.
[20]
D’Eufemia P., Celli M., Finocchiaro R. et al.: Abnormal intestinal
permeability in children with autism. Acta Paediatr 1996; 85: 1076
– 1079.
[21]
Knivsberg A.M., Reichelt K.L., Hoien T. et al.: A randomized, controlled
study of dietary intervention in autistic syndromes. Nutr Neurosci 2002;
5(4): 251 – 61.
[22]
Elder J.H.: The gluten free, casein free diet in autism: an overview with
clinical implications. Nutr Clin Pract 2008; 23 (6): 583 – 588.
[23]
Jyonouchi H., Geng L., Ruby A. et al.: Disregulated innate immune
responses in young children with Autism Spectrum Disorders: their
relationship to gastrointestinal symptoms and dietary intervention.
Neuropsychobiology 2005; 51: 77-85.
[24]
Jyonouchi H., Geng L., Ruby A. et al.: Evaluation of an association
between gastrointestinal symptoms and cytokine production against
common dietary proteins in children with autism spectrum disorders.
Neuropsychobiology 2005; 146: 582-584.
[25]
Paracho H.M., Bringham M.O., Gibson G.R. et al.: Differences between
gut microflora of children with autistic spectrum disorders and that of
healthy children. J Med Microbiol 2005; 54: 981-987.
[26]
Furlando R.I., Anthony A., Day Ret P. al.: Colonic CD8 and gamma delta
T - cell infiltration with epithelial damage in children with autism. J
Paediatr 2001; 138: 366 – 372.
[27]
Wakefield A.J., Anthony A., Murch S.H. et al.: Enterocolitis in children
with developmental disorders. Am J Gastroenterol 2000; 95: 2285
– 2295.
[28]
Wakefield A.J.: The gut-brain-axis in childhood developmental disorders.
J Ped Gastroent Nut 2002; 34: 14- 17.
[29]
Connoly A.M., Chez G.M., Pestronk A. et al.: Serum auto-antibodies to
brain in Landau Kleffner variant, autism, and other neurological disorders.
J Paediatr 1999; 134: 607 – 613.
[30]
Valicenti – Mc Dermott M.D., McVicar K., Cohen H.J. et al.:
Gastrointestinal symptoms in children with autism spectrum disorder
and language regression. Ped Neurol 2008; 39: 392 – 398.
[31]
Gershon M.D. Review article: roles played by 5-HT in the physiology of
the bowel. Alliment Pharmacol Ther 1999; 13: 15 – 30.
[32]
Buie T., Campbell D.B., Fuchs J.G. et al.: Evaluation, diagnosis and
treatment of gastrointestinal disorders in individuals with ASDs:
a consensus report. Pediatrics 2010, 125 (Suppl 1): 1 – 18.
Scholar Google
PubMed